Symbols / ELTX $11.98 -1.64% Elicio Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
ELTX Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 220.38M Enterprise Value 220.01M Income -39.57M Sales — Book/sh 0.09 Cash/sh 1.01
Dividend Yield — Payout 0.00% Employees 33 IPO — P/E — Forward P/E -6.77
PEG — P/S — P/B 130.22 P/C — EV/EBITDA -5.87 EV/Sales —
Quick Ratio 2.29 Current Ratio 2.38 Debt/Eq 887.04 LT Debt/Eq — EPS (ttm) -2.58 EPS next Y -1.77
EPS Growth — Revenue Growth — Earnings 2026-03-12 ROA -87.24% ROE — ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 18.40M Shs Float 12.71M Short Float 10.31%
Short Ratio 8.85 Short Interest — 52W High 14.93 52W Low 4.70 Beta 1.88 Avg Volume 143.62K
Volume 51.27K Target Price $18.33 Recom Strong_buy Prev Close $12.18 Price $11.98 Change -1.64%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-21.20
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest ELTX news

No recent news from Yahoo. Try the RSS feed for latest ELTX news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-02 CONNELLY ROBERT Chief Executive Officer — 73,600 $0.00 $0
2026-02-02 HAQQ CHRISTOPHER Officer — 25,400 $0.00 $0
2026-02-02 SHAH PREETAM Chief Financial Officer — 24,000 $0.00 $0
2025-12-09 DEMUTH PETER Officer — 362 $4.41 $1,596
2025-03-05 CHUDNOVSKY YEKATERINA Director and Beneficial Owner of more than 10% of a Class of Security — 3,500,573 $5.81 $20,338,329
2024-12-16 DEMUTH PETER Officer — 381 $4.41 $1,680
2024-11-26 VENKATESAN JAY R Director — 50,000 $0.01 $500
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category